Cargando…
Targeting Protein-Protein Interactions to Inhibit Cyclin-Dependent Kinases
Cyclin-dependent kinases (CDKs) play diverse and critical roles in normal cells and may be exploited as targets in cancer therapeutic strategies. CDK4 inhibitors are currently approved for treatment in advanced breast cancer. This success has led to continued pursuit of targeting other CDKs. One cha...
Autor principal: | Klein, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144709/ https://www.ncbi.nlm.nih.gov/pubmed/37111276 http://dx.doi.org/10.3390/ph16040519 |
Ejemplares similares
-
Two maize Kip-related proteins differentially interact with, inhibit and are phosphorylated by cyclin D–cyclin-dependent kinase complexes
por: Godínez-Palma, Silvia K., et al.
Publicado: (2017) -
Protein kinase Cα: disease regulator and therapeutic target
por: Konopatskaya, Olga, et al.
Publicado: (2010) -
Cyclin-Dependent Kinase 6 Identified as the Target Protein in the Antitumor Activity of Tetrastigma hemsleyanum
por: Wei, Chaoguang, et al.
Publicado: (2022) -
Proteomic Interaction Patterns between Human Cyclins, the Cyclin-Dependent Kinase Ortholog pUL97 and Additional Cytomegalovirus Proteins
por: Steingruber, Mirjam, et al.
Publicado: (2016) -
Therapeutic targeting of transcriptional cyclin-dependent kinases
por: Galbraith, Matthew D., et al.
Publicado: (2018)